Metabolic Syndrome Clinical Trial
Official title:
Validity of the Vyntus CPX Metabolic Cart for Assessing Postprandial Energy Expenditure and Respiratory Exchange Ratio
The aims of the present study are described below: Aim 1: In-vitro measures to determine the validity, precision and accuracy of the Vyntus CPX metabolic cart assessed by: 1.1. Methanol burning tests. 1.2. Pure gas (nitrogen [N2] and carbon dioxide [CO2]) infusions to simulate both, constant and variable fluxes of oxygen consumption (VO2) and carbon dioxide production (VCO2) in different conditions and moments. 1. Immediately after or prior the methanol burning test (in a randomized order). 2. In separate days and time-periods. Aim 2: In-vivo measures using the Vyntus CPX metabolic cart: 2.1. To assess the resting metabolic rate (RMR or resting energy expenditure [REE]) and respiratory exchange ratio (RER) day-to-day biological reproducibility (i.e. reliability) of the metabolic cart. 2.2. Further, the investigators will use an oral glucose tolerance test (OGTT) to determine the post-prandial day-to-day biological reproducibility (especifically the post-prandial RER) of the metabolic cart.
Status | Recruiting |
Enrollment | 12 |
Est. completion date | March 23, 2022 |
Est. primary completion date | February 23, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - Healthy. - Age 18-40 y. - BMI between 18.5 kg/m2 and 30 kg/m2 (both inclusive). - Willing to fast and not to consume non-caloric stimulant for 12h before the assessments. - Willing to avoid moderate or vigorous physical activity during 24-48h respectively. - Have a stable body weight over the last 3 months (changes =3 kg) and not being enrolled in a weight loss program. Exclusion Criteria: - Smoking or use of tobacco products within the last 3 months. - Diagnosed with diabetes. - Previous bariatric surgery (or other surgeries) for obesity or weight loss. - Use of medications affecting metabolism or sleep. - History of neurological disease. - History of cardiovascular disease, including hypertension, or other chronic diseases. - Pregnant, planning to become pregnant, or breastfeeding. - Adherence to special restrained diets (e.g., low-carbohydrates, low-fat, or vegetarian/vegan diets) over the last 3 months. - Claustrophobia impeding to stay calm under a plastic canopy. |
Country | Name | City | State |
---|---|---|---|
Spain | University of Granada | Granada |
Lead Sponsor | Collaborator |
---|---|
Universidad de Granada |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | VO2 post-prandial gas exchange assessed by indirect calorimetry | Volume of oxygen consumption (VO2 [ml/min]) | 5 hours | |
Primary | VCO2 post-prandial gas exchange assessed by indirect calorimetry | Volume of carbon dioxide production (VCO2 [ml/min]) | 5 hours | |
Primary | EE post-prandial gas exchange assessed by indirect calorimetry | -Energy Expenditure (EE [kcal/day]) | 5 hours | |
Primary | RER post-prandial gas exchange assessed by indirect calorimetry | Respiratory Exchange Ratio (RER [calculated as VCO2-to-VO2 ratio]) | 5 hours | |
Primary | CHOox post-prandial gas exchange assessed by indirect calorimetry | Carbohydrate oxidation (CHOox [g/min]) | 5 hours | |
Primary | FATox post-prandial gas exchange assessed by indirect calorimetry | Fat oxidation (FATox [g/min]) | 5 hours | |
Primary | VO2 validity of the metabolic cart. In-vitro measurements and/or simulations to determine the validity, precision and accuracy of the metabolic cart assessed by methanol burning tests and controlled pure gas infusions. | Volume of oxygen consumption (VO2) measurement error (ml/min) | 14 separate days; measurements of 2 hours per day | |
Primary | VCO2 validity of the metabolic cart. In-vitro measurements and/or simulations to determine the validity, precision and accuracy of the metabolic cart assessed by methanol burning tests and controlled pure gas infusions. | Volume of carbon dioxide production (VCO2) measurement error (ml/min) | 14 separate days; measurements of 2 hours per day | |
Primary | EE validity of the metabolic cart. In-vitro measurements and/or simulations to determine the validity, precision and accuracy of the metabolic cart assessed by methanol burning tests and controlled pure gas infusions. | Energy Expenditure (EE) measurement error (kcal/day) | 14 separate days; measurements of 2 hours per day | |
Primary | RER validity of the metabolic cart. In-vitro measurements and/or simulations to determine the validity, precision and accuracy of the metabolic cart assessed by methanol burning tests and controlled pure gas infusions. | Respiratory Exchange Ratio (RER) measurement error | 14 separate days; measurements of 2 hours per day | |
Secondary | Post-prandial blood glucose concentrations | Measures of blood glucose concentrations (mg/dl) | 5 hours | |
Secondary | Body composition outcomes (DXA scann) | Lean mass, fat-free mass and fat mass in kilograms | 1 day | |
Secondary | Anthropometric measurements 1, weight | Weight in kilograms | 1 day | |
Secondary | Anthropometric measurements 2, height | Height in meters | 1 day | |
Secondary | Anthropometric measurements 3, body mass index | BMI: Weight and height will be combined to report in kg/m^2 | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04635202 -
Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome
|
N/A | |
Completed |
NCT04053686 -
An Intervention to Reduce Prolonged Sitting in Police Staff
|
N/A | |
Completed |
NCT05343858 -
Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Recruiting |
NCT05040958 -
Carotid Atherosclerotic Plaque Load and Neck Circumference
|
||
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Completed |
NCT03289897 -
Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
Active, not recruiting |
NCT03613740 -
Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
|
Phase 2 | |
Completed |
NCT04498455 -
Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
|
Phase 4 | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03697382 -
Effect of Daily Steps on Fat Metabolism
|
N/A | |
Completed |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
Completed |
NCT04509206 -
Virtual Teaching Kitchen
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A |